However, induction of hyperglycemia in vivo influences insulin production and levels, which impacts myocardial ischemia–reperfusion injury [45] and may influence myocardial glucose uptake and O-GlcNAc levels differently in T2DM and non-diabetic hearts. The gene discussed is INS; the disease is Hyperglycemia.